These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9407465)

  • 1. Macrophage and myofibroblast proliferation in remnant kidney: role of angiotensin II.
    Wu LL; Yang N; Roe CJ; Cooper ME; Gilbert RE; Atkins RC; Lan HY
    Kidney Int Suppl; 1997 Dec; 63():S221-5. PubMed ID: 9407465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II.
    Yu XQ; Wu LL; Huang XR; Yang N; Gilbert RE; Cooper ME; Johnson RJ; Lai KN; Lan HY
    Kidney Int; 2000 Oct; 58(4):1469-80. PubMed ID: 11012882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring.
    Klahr S; Morrissey JJ
    Kidney Int Suppl; 1997 Dec; 63():S111-4. PubMed ID: 9407436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N; Vuolteenaho O; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney.
    Yang N; Wu LL; Nikolic-Paterson DJ; Ng YY; Yang WC; Mu W; Gilbert RE; Cooper ME; Atkins RC; Lan HY
    Nephrol Dial Transplant; 1998 Aug; 13(8):1967-74. PubMed ID: 9719149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
    Vaziri ND; Bai Y; Ni Z; Quiroz Y; Pandian R; Rodriguez-Iturbe B
    J Pharmacol Exp Ther; 2007 Oct; 323(1):85-93. PubMed ID: 17636006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous angiotensin II and the reflex response to stimulation of cardiopulmonary serotonin 5HT3 receptors.
    Veelken R; Hilgers KF; Scrogin KE; Mann JF; Schmieder RE
    Br J Pharmacol; 1998 Dec; 125(8):1761-7. PubMed ID: 9886768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II formation in the kidney and nephrosclerosis in Ren-2 hypertensive rats.
    Hartner A; Porst M; Klanke B; Cordasic N; Veelken R; Hilgers KF
    Nephrol Dial Transplant; 2006 Jul; 21(7):1778-85. PubMed ID: 16522658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension.
    Seccia TM; Belloni AS; Guidolin D; Sticchi D; Nussdorfer GG; Pessina AC; Rossi GP
    J Hypertens; 2006 Jul; 24(7):1419-27. PubMed ID: 16794493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular mRNA expression of angiotensinase A after renal ablation.
    Wolf G; Thaiss F; Mueller E; Disser M; Pooth R; Zahner G; Stahl RA
    Exp Nephrol; 1995; 3(4):240-8. PubMed ID: 8590037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valsartan inhibited the accumulation of dendritic cells in rat fibrotic renal tissue.
    Wu K; Zhou T; Sun G; Wang W; Zhang Y; Zhang Y; Hao L; Chen N
    Cell Mol Immunol; 2006 Jun; 3(3):213-20. PubMed ID: 16893502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney angiotensin receptors and their role in renal pathophysiology.
    Sandberg K; Ji H
    Semin Nephrol; 2000 Sep; 20(5):402-16. PubMed ID: 11022892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries.
    Kitayama H; Maeshima Y; Takazawa Y; Yamamoto Y; Wu Y; Ichinose K; Hirokoshi K; Sugiyama H; Yamasaki Y; Makino H
    Am J Hypertens; 2006 Jul; 19(7):718-27. PubMed ID: 16814127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between renin angiotensin system and advanced glycation in the kidney.
    Thomas MC; Tikellis C; Burns WM; Bialkowski K; Cao Z; Coughlan MT; Jandeleit-Dahm K; Cooper ME; Forbes JM
    J Am Soc Nephrol; 2005 Oct; 16(10):2976-84. PubMed ID: 16107577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor blockade and progression of nondiabetic-mediated renal disease.
    Tarif N; Bakris GL
    Kidney Int Suppl; 1997 Dec; 63():S67-70. PubMed ID: 9407425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair.
    Weber KT
    Semin Nephrol; 1997 Sep; 17(5):467-91. PubMed ID: 9316215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased osteopontin expression following renal ablation is attenuated by angiotensin type 1 receptor antagonism.
    Cao Z; Cox A; Bonnet F
    Exp Nephrol; 2002; 10(1):19-25. PubMed ID: 11803201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective effect of catechin on renal microvessels in 5/6 nephrectomized rats and its mechanism].
    Cao Y; He XJ; Xiang W; Yi ZW
    Zhong Xi Yi Jie He Xue Bao; 2009 Jun; 7(6):557-62. PubMed ID: 19583939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.